Please use this identifier to cite or link to this item: http://111.93.178.142:25000/jspui/handle/123456789/5277
Full metadata record
DC FieldValueLanguage
dc.contributor.authorTajinder Singh-
dc.date.accessioned2026-06-12T11:35:35Z-
dc.date.available2026-06-12T11:35:35Z-
dc.date.issued2026-06-12-
dc.identifier.urihttp://111.93.178.142:25000/jspui/handle/123456789/5277-
dc.descriptionVol. 35, No. 3, p 703en_US
dc.language.isoenen_US
dc.subjectBreast canceren_US
dc.subjectAbsorptionen_US
dc.subjectAbsorptionen_US
dc.subjectdistributionen_US
dc.subjectmetabolismen_US
dc.subjectexcretionen_US
dc.titleIn silico evaluation of quinoline of quinoline -piperazine hybrids targeting breast cancer pathwaysen_US
dc.typeOtheren_US
Appears in Collections:Vol. 35, No. 3, 2025

Files in This Item:
File Description SizeFormat 
1.pdfVol. 35, No. 3, p 703239.18 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.